Meeting
2018 Genitourinary Cancers Symposium
Defining individual recurrence risk following surgery for high risk non-metastatic renal cell carcinoma.
Authors
Edwin J Abel
University of Wisconsin School of Medicine and Public Health, Madison, WI
Edwin J Abel , Jay D. Raman , Daniel D Shapiro , Wilson Chan , Glenn O. Allen , Dattatraya Patil , Viraj A. Master
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 664)
DOI
10.1200/JCO.2018.36.6_suppl.664
Abstract #
664
Poster Bd #
J15
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
ctDNA monitoring for breast cancer at high risk of recurrence: Interim analysis of JCOG1204A1.
First Author: Yoichi Naito
Poster
2024 ASCO Genitourinary Cancers Symposium
Prostate-specific membrane antigen expression in endothelial cells of renal tumor-associated neovasculature and risk of recurrence for renal cell carcinoma.
First Author: Tadahiko Kikugawa
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Adjuvant TACE plus lenvatinib as compared with TACE alone in patients with hepatocellular carcinoma at high risk of recurrence after surgery: A prospective controlled study.
First Author: Bin Zhang
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Adjuvant chemoradiotherapy (CRT) plus pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC) with high risk of recurrence after neoadjuvant CRT plus surgery: A single-arm phase II study.
First Author: Jhe-Cyuan Guo